CoolSculpting Was Just Discontinued Globally: Here Is What Every Indian Patient Needs to Know

Why CoolSculpting was pulled from the global market, what Indian clinics are still not telling patients, and what non-surgical body contouring options actually work instead.

I am Dr. Pooja Varshney, a dermatologist practising since 2015. I treat a wide range of cosmetic and medical concerns and body contouring has been an increasingly common consultation in the last three years. I am writing this because a conversation I have been having privately in my clinic needs to be said publicly.

CoolSculpting, the fat freezing procedure that became one of the most recognised non-surgical body contouring treatments in the world, was discontinued by its manufacturer Allergan Aesthetics in 2023. The CoolSculpting and CoolTone product lines were pulled from the global market. This is not a rumour. It is a documented corporate decision that was widely reported in international medical and aesthetic industry publications.

Most patients have no idea. That is the problem I am here to address.

What CoolSculpting Was and Why It Was Discontinued

How CoolSculpting Fat Freezing Actually Worked

CoolSculpting used a technology called cryolipolysis, controlled cooling applied to targeted fat deposits to trigger apoptosis, the natural death of fat cells. When fat cells are cooled to specific temperatures, they crystallise and die. The body then naturally eliminates these dead fat cells over the following weeks and months.

The technology was clinically validated and FDA cleared. Studies demonstrated meaningful reduction in fat layer thickness in treated areas. For patients who were appropriate candidates, results were real and measurable. CoolSculpting was not a scam in the sense that the underlying science was sound.

Why Allergan Discontinued CoolSculpting in 2023

Allergan Aesthetics announced the discontinuation of the CoolSculpting and CoolTone product lines in July 2023, citing a strategic portfolio decision to focus resources on other areas of their business. The official reason given was business strategy rather than safety concerns.

However, the context around the discontinuation is important for patients to understand. CoolSculpting had faced significant litigation related to a rare but serious complication called paradoxical adipose hyperplasia, or PAH, in which treated fat cells instead of dying actually grew larger, creating a firm, visible bulge in the treated area that is extremely difficult to treat and in many cases requires surgical intervention to address. Multiple high profile cases including a widely publicised lawsuit brought by television personality Linda Evangelista brought significant media attention to this complication.

Whether the discontinuation was purely a business decision or influenced by the liability landscape, the result is the same. The manufacturer no longer supports the product. Devices in clinics are operating without manufacturer support, without access to updated protocols, and without the clinical infrastructure that should accompany an active medical device programme.

What Indian Clinics Are Still Not Telling Patients About CoolSculpting

The Informed Consent Problem

When a patient books a CoolSculpting session in India today, they deserve to know that the treatment they are receiving uses a device from a discontinued product line that the manufacturer no longer supports. This is material information that affects the informed consent process. A patient cannot meaningfully consent to a procedure without knowing this.

I am not suggesting that CoolSculpting devices in Indian clinics are unsafe in a direct sense. The physics of cryolipolysis does not change because a company discontinued a product. But the absence of manufacturer support means no updated training, no updated protocols, no direct line of communication if something goes wrong, and no recourse through the manufacturer if a complication like PAH occurs.

This context should be part of every CoolSculpting consultation in India. In most clinics, it is not mentioned at all.

Paradoxical Adipose Hyperplasia: The Complication Nobody Mentions

PAH is estimated to occur in approximately 0.0051% of CoolSculpting treatments according to earlier manufacturer data, though independent researchers and clinicians have suggested the actual rate may be higher as reporting has historically been underrepresented. For a treatment that was performed millions of times globally, even a small percentage represents a meaningful number of affected patients.

PAH creates a firm, well-defined mass of enlarged fat tissue in the treated area that appears two to five months after treatment, long after the initial treatment period when most patients assume they are through any risk window. It does not resolve on its own. It requires liposuction to address and even after surgical correction, some patients experience residual contour irregularities.

A patient booking body contouring treatment in Gurgaon should know this complication exists, what it looks like, and what the plan is if it occurs. Most are never told.

What Actually Works for Non-Surgical Fat Reduction in 2026

Lipolysis Injections — The Most Effective Non-Surgical Fat Reduction Available Now

Lipolysis injections, using deoxycholic acid or phosphatidylcholine formulations, dissolve targeted fat deposits through a different mechanism than cryolipolysis. The active compound disrupts the fat cell membrane, causing the fat cell to break down and be eliminated through the body's natural metabolic processes.

For targeted areas including submental fat, the double chin, localised fat deposits on the abdomen, flanks, inner thighs and arms, lipolysis injections produce clinically significant and lasting fat reduction. The fat cells that are destroyed do not regenerate. Results are permanent as long as the patient maintains a stable weight.

The treatment requires multiple sessions spaced four to six weeks apart and results develop gradually over two to three months as the body processes the destroyed fat cells. For patients who are appropriate candidates, meaning those with localised fat deposits rather than generalised obesity, the results are comparable to what CoolSculpting delivered and are achieved with an active, manufacturer supported treatment option.

Body Tightening — Addressing What Fat Reduction Alone Cannot

One of the clinical limitations of fat reduction treatments, both cryolipolysis and lipolysis, is that reducing the fat volume in an area does not address skin laxity. In patients with reduced skin elasticity, particularly those over 35 or those who have experienced significant weight fluctuation, fat reduction without concurrent skin tightening can leave the skin looking looser rather than more contoured.

Body tightening treatments using radiofrequency energy address this by stimulating collagen production and skin contraction in the treatment area. Combining lipolysis injections with RF body tightening produces results that address both the fat volume and the skin quality simultaneously, which is why this combination approach has become the standard of care for non-surgical body contouring in well-equipped aesthetic clinics.

Medical Weight Management: When Non-Surgical Contouring Is Not Enough

For patients whose concern is not localised fat deposits but generalised weight that affects overall body composition, non-surgical fat reduction treatments are not the appropriate starting point. Treatments like lipolysis and CoolSculpting are designed for patients who are at or near their healthy weight with specific areas of resistant fat. They are not substitutes for weight management.

For patients who need medical support for weight management, DermaTales weight loss clinic in Gurgaon offers medically supervised programmes including GLP-1 receptor agonist therapy, which has transformed the weight management landscape globally and produces significantly more comprehensive fat reduction than any body contouring treatment.

If You Have Already Paid for CoolSculpting Sessions

If you have pre-paid for CoolSculpting sessions at a clinic and have not completed them, you are entitled to ask your clinic directly what device they are using, when it was last serviced, whether it is operating with manufacturer support, and what their protocol is if PAH occurs. These are reasonable clinical questions that any reputable clinic should answer transparently.

If you have completed CoolSculpting sessions recently and notice a firm, growing bulge in the treated area in the two to five month window after treatment, see a dermatologist promptly. Early identification of PAH before the tissue fully firms gives more options for management.

Frequently Asked Questions About CoolSculpting and Non-Surgical Fat Reduction

About Dr. Pooja Varshney

Dr. Pooja Varshney (MBBS, MD Dermatology) is a Consultant Dermatologist and Aesthetic Physician practising since 2015. She specialises in medical, cosmetic and hair dermatology and leads DermaTales Skin Clinic across Gurugram and Delhi.